Medicamen Biotech Ltd.
•₹ 244.550.33%
2026-08-21
PROS
- Company has consistently been profitable over the last 5 years
- Company has a consistent dividend-paying track record
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (63.2% of PBT)
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on equity of 5.8% over last 3 years
- Company has a low return on capital employed of 8.4%
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.69x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | MEDICAMEQ | 229.15 | 28.70 | 310.79 | 0.44 | 1.85 | 15.30 | 47.90 | 11.26 | 5.77 | 9.03 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42 | 44 | 46 | 47 | 43 | 45 | 45 | 30 | 43 | 47 | 47 | 61 | 48 | |
| 35 | 39 | 42 | 42 | 40 | 39 | 38 | 31 | 38 | 42 | 43 | 55 | 46 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 5 | 0 | 0 | 1 | 2 | 1 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 0 | 2 | 2 | 2 | 2 | 2 |
| 5 | 2 | 3 | 3 | 2 | 2 | 4 | 2 | 2 | 3 | 2 | 5 | 3 | |
| Tax % | 15.81% | 40.08% | 37.92% | 23.31% | 48.72% | 53.57% | 24.74% | 25.30% | 24.88% | 21.27% | 22.75% | 12.06% | 28.24% |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 2 | 2 | 2 | 2 | 4 | 2 |
| 3 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 3 | 0 | |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 42
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 5
- Tax %
- 15.81%
- Net Profit
- 0
- 3
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 44
- 39
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 40.08%
- Net Profit
- 0
- 1
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 46
- 42
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 37.92%
- Net Profit
- 0
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 47
- 42
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 2
- 3
- Tax %
- 23.31%
- Net Profit
- 0
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 43
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 48.72%
- Net Profit
- 1
- 1
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 45
- 39
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 3
- 2
- Tax %
- 53.57%
- Net Profit
- 1
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 45
- 38
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 4
- Tax %
- 24.74%
- Net Profit
- 3
- 2
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 30
- 31
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 1
- Depreciation
- 0
- 2
- Tax %
- 25.30%
- Net Profit
- 2
- 1
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 43
- 38
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 24.88%
- Net Profit
- 2
- 1
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 47
- 42
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 21.27%
- Net Profit
- 2
- 2
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 47
- 43
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 22.75%
- Net Profit
- 2
- 1
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 61
- 55
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 0
- Depreciation
- 2
- 5
- Tax %
- 12.06%
- Net Profit
- 4
- 3
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 48
- 46
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 28.24%
- Net Profit
- 2
- 0
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 14
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 123 | 126 | 113 | 115 | 141 | 179 | 163 | 203 | |
| 105 | 106 | 93 | 91 | 117 | 156 | 148 | 186 | |
| Operating Profit | 21 | 21 | 20 | 26 | 27 | 26 | 21 | — |
| OPM % | 17 | 17 | 18 | 22 | 19 | 14 | 13 | — |
| Other Income | 4 | 2 | 1 | 2 | 2 | 2 | 6 | 4 |
| Interest | 1 | 1 | 2 | 2 | 3 | 6 | 4 | 3 |
| Depreciation | 2 | 2 | 3 | 6 | 6 | 7 | 7 | 7 |
| 18 | 18 | 16 | 18 | 17 | 13 | 10 | 12 | |
| Tax % | 31 | 26 | 26 | 18 | 14 | 27 | 34 | 19 |
| Net Profit | 12 | 13 | 12 | 15 | 15 | 9 | 7 | 10 |
| EPS | 0 | 0 | 10 | 12 | 12 | 7 | 5 | — |
| Dividend Payout % | 10 | 5 | 10 | 8 | 9 | 13 | 19 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 11 | 10 | 12 | 12 | 7 | 5 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 11 | 10 | 12 | 12 | 7 | 5 | — |
Mar 2019
- 123
- 105
- Operating Profit
- 21
- OPM %
- 17
- Other Income
- 4
- Interest
- 1
- Depreciation
- 2
- 18
- Tax %
- 31
- Net Profit
- 12
- EPS
- 0
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2020
- 126
- 106
- Operating Profit
- 21
- OPM %
- 17
- Other Income
- 2
- Interest
- 1
- Depreciation
- 2
- 18
- Tax %
- 26
- Net Profit
- 13
- EPS
- 0
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
Mar 2021
- 113
- 93
- Operating Profit
- 20
- OPM %
- 18
- Other Income
- 1
- Interest
- 2
- Depreciation
- 3
- 16
- Tax %
- 26
- Net Profit
- 12
- EPS
- 10
- Dividend Payout %
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2022
- 115
- 91
- Operating Profit
- 26
- OPM %
- 22
- Other Income
- 2
- Interest
- 2
- Depreciation
- 6
- 18
- Tax %
- 18
- Net Profit
- 15
- EPS
- 12
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2023
- 141
- 117
- Operating Profit
- 27
- OPM %
- 19
- Other Income
- 2
- Interest
- 3
- Depreciation
- 6
- 17
- Tax %
- 14
- Net Profit
- 15
- EPS
- 12
- Dividend Payout %
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
Mar 2024
- 179
- 156
- Operating Profit
- 26
- OPM %
- 14
- Other Income
- 2
- Interest
- 6
- Depreciation
- 7
- 13
- Tax %
- 27
- Net Profit
- 9
- EPS
- 7
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2025
- 163
- 148
- Operating Profit
- 21
- OPM %
- 13
- Other Income
- 6
- Interest
- 4
- Depreciation
- 7
- 10
- Tax %
- 34
- Net Profit
- 7
- EPS
- 5
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
TTM
- 203
- 186
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 3
- Depreciation
- 7
- 12
- Tax %
- 19
- Net Profit
- 10
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 5%
- 3 Years:
- 12%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- -13%
- 3 Years:
- -24%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- -31%
- 1 Year:
- -32%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 8%
- 3 Years:
- 6%
- Last Year:
- 3%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 12 | 12 | 12 | 12 | 13 | 13 | 13 |
| 75 | 109 | 121 | 134 | 178 | 194 | 200 | |
| 12 | 8 | 12 | 21 | 23 | 30 | 30 | |
| Trade Payables | 31 | 37 | 32 | 43 | 48 | 39 | 43 |
| 8 | 15 | 16 | 15 | 15 | 17 | 9 | |
| Total Liabilities | 137 | 181 | 194 | 225 | 277 | 292 | 294 |
| ASSETS | - | - | - | - | - | - | - |
| 24 | 34 | 90 | 92 | 93 | 92 | 87 | |
| Capital Work in Progress | 15 | 40 | 0 | 0 | 0 | 0 | 0 |
| 15 | 17 | 5 | 27 | 45 | 59 | 62 | |
| 0 | 0 | 0 | 0 | 0 | 55 | 69 | |
| Cash & Bank | 9 | 3 | 4 | 4 | 21 | 15 | 4 |
| 74 | 87 | 95 | 102 | 118 | 71 | 72 | |
| Total Assets | 137 | 181 | 194 | 225 | 277 | 292 | 294 |
| Total Debt | 12 | 11 | 19 | 26 | 26 | 31 | 34 |
| Net Working Capital | 48 | 48 | 43 | 50 | 81 | 75 | 86 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 73.69 | 97.55 | 103.33 | 113.56 | 145.25 | 157.52 | 162.23 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 12 | 11 | 19 | 26 | 26 | 31 | 34 |
| Net Working Capital | 48 | 48 | 43 | 50 | 81 | 75 | 86 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 73.69 | 97.55 | 103.33 | 113.56 | 145.25 | 157.52 | 162.23 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2019
- Equity Capital
- 12
- 75
- 12
- Trade Payables
- 31
- 8
- Total Liabilities
- 137
- 24
- Capital Work in Progress
- 15
- 15
- 0
- Cash & Bank
- 9
- 74
- Total Assets
- 137
- Total Debt
- 12
- Net Working Capital
- 48
- Contingent Liabilities
- 0
- Book Value per Share
- 73.69
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- 48
- Contingent Liabilities
- 0
- Book Value per Share
- 73.69
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 12
- 109
- 8
- Trade Payables
- 37
- 15
- Total Liabilities
- 181
- 34
- Capital Work in Progress
- 40
- 17
- 0
- Cash & Bank
- 3
- 87
- Total Assets
- 181
- Total Debt
- 11
- Net Working Capital
- 48
- Contingent Liabilities
- 0
- Book Value per Share
- 97.55
- Face Value
- 10.00
- Total Debt
- 11
- Net Working Capital
- 48
- Contingent Liabilities
- 0
- Book Value per Share
- 97.55
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 12
- 121
- 12
- Trade Payables
- 32
- 16
- Total Liabilities
- 194
- 90
- Capital Work in Progress
- 0
- 5
- 0
- Cash & Bank
- 4
- 95
- Total Assets
- 194
- Total Debt
- 19
- Net Working Capital
- 43
- Contingent Liabilities
- 0
- Book Value per Share
- 103.33
- Face Value
- 10.00
- Total Debt
- 19
- Net Working Capital
- 43
- Contingent Liabilities
- 0
- Book Value per Share
- 103.33
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 12
- 134
- 21
- Trade Payables
- 43
- 15
- Total Liabilities
- 225
- 92
- Capital Work in Progress
- 0
- 27
- 0
- Cash & Bank
- 4
- 102
- Total Assets
- 225
- Total Debt
- 26
- Net Working Capital
- 50
- Contingent Liabilities
- 0
- Book Value per Share
- 113.56
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 50
- Contingent Liabilities
- 0
- Book Value per Share
- 113.56
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 13
- 178
- 23
- Trade Payables
- 48
- 15
- Total Liabilities
- 277
- 93
- Capital Work in Progress
- 0
- 45
- 0
- Cash & Bank
- 21
- 118
- Total Assets
- 277
- Total Debt
- 26
- Net Working Capital
- 81
- Contingent Liabilities
- 0
- Book Value per Share
- 145.25
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 81
- Contingent Liabilities
- 0
- Book Value per Share
- 145.25
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 13
- 194
- 30
- Trade Payables
- 39
- 17
- Total Liabilities
- 292
- 92
- Capital Work in Progress
- 0
- 59
- 55
- Cash & Bank
- 15
- 71
- Total Assets
- 292
- Total Debt
- 31
- Net Working Capital
- 75
- Contingent Liabilities
- 0
- Book Value per Share
- 157.52
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- 75
- Contingent Liabilities
- 0
- Book Value per Share
- 157.52
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 13
- 200
- 30
- Trade Payables
- 43
- 9
- Total Liabilities
- 294
- 87
- Capital Work in Progress
- 0
- 62
- 69
- Cash & Bank
- 4
- 72
- Total Assets
- 294
- Total Debt
- 34
- Net Working Capital
- 86
- Contingent Liabilities
- 0
- Book Value per Share
- 162.23
- Face Value
- 10.00
- Total Debt
- 34
- Net Working Capital
- 86
- Contingent Liabilities
- 0
- Book Value per Share
- 162.23
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 4 | 13 | 13 | 4 | -6 | -7 | -8 | |
| Cash from Investing | -15 | -37 | -18 | -8 | -6 | -6 | -1 |
| Cash from Financing | -4 | 19 | 6 | 4 | 29 | 6 | -1 |
| -14 | -5 | 1 | -0 | 17 | -6 | -11 | |
| Free Cash Flow | 4 | -24 | -5 | -4 | -12 | -13 | -10 |
| OCF / Net Profit | 0.36 | 0.96 | 1.05 | 0.28 | -0.43 | -0.71 | -1.24 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -59 | -45 |
| OCF / Net Profit | 0.36 | 0.96 | 1.05 | 0.28 | -0.43 | -0.71 | -1.24 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -59 | -45 |
Mar 2019
- 4
- Cash from Investing
- -15
- Cash from Financing
- -4
- -14
- Free Cash Flow
- 4
- OCF / Net Profit
- 0.36
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.36
- Cumulative 5-Year FCF
- 0
Mar 2020
- 13
- Cash from Investing
- -37
- Cash from Financing
- 19
- -5
- Free Cash Flow
- -24
- OCF / Net Profit
- 0.96
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.96
- Cumulative 5-Year FCF
- 0
Mar 2021
- 13
- Cash from Investing
- -18
- Cash from Financing
- 6
- 1
- Free Cash Flow
- -5
- OCF / Net Profit
- 1.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.05
- Cumulative 5-Year FCF
- 0
Mar 2022
- 4
- Cash from Investing
- -8
- Cash from Financing
- 4
- -0
- Free Cash Flow
- -4
- OCF / Net Profit
- 0.28
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.28
- Cumulative 5-Year FCF
- 0
Mar 2023
- -6
- Cash from Investing
- -6
- Cash from Financing
- 29
- 17
- Free Cash Flow
- -12
- OCF / Net Profit
- -0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.43
- Cumulative 5-Year FCF
- 0
Mar 2024
- -7
- Cash from Investing
- -6
- Cash from Financing
- 6
- -6
- Free Cash Flow
- -13
- OCF / Net Profit
- -0.71
- Cumulative 5-Year FCF
- -59
- OCF / Net Profit
- -0.71
- Cumulative 5-Year FCF
- -59
Mar 2025
- -8
- Cash from Investing
- -1
- Cash from Financing
- -1
- -11
- Free Cash Flow
- -10
- OCF / Net Profit
- -1.24
- Cumulative 5-Year FCF
- -45
- OCF / Net Profit
- -1.24
- Cumulative 5-Year FCF
- -45
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 10.28 | 10.88 | 9.93 | 12.19 | 11.64 | 7.47 | 5.16 |
| Book Value (₹) | 73.69 | 97.55 | 103.33 | 113.56 | 145.25 | 157.52 | 162.23 |
| Dividend per Share (₹) | 1.00 | 0.50 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Cash EPS (₹) | 12.17 | 12.93 | 11.99 | 16.92 | 16.67 | 13.05 | 10.71 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 17.23% | 17.06% | 18.12% | 22.35% | 19.03% | 13.11% | 8.87% |
| Net Margin % | 9.81% | 10.59% | 10.76% | 12.90% | 10.46% | 5.29% | 4.03% |
| ROE % | 13.95% | 12.94% | 9.89% | 11.25% | 9.13% | 4.94% | 3.23% |
| ROCE % | 19.30% | 16.54% | 12.99% | 12.94% | 10.85% | 8.46% | 5.77% |
| 8.80% | 8.36% | 6.46% | 7.11% | 5.87% | 3.34% | 2.24% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 129 | 136 | 166 | 183 | 166 | 123 | 139 |
| Inventory Days | 45 | 47 | 36 | 51 | 93 | 106 | 136 |
| Payable Days | 161 | 189 | 254 | 317 | 311 | 216 | 226 |
| 13 | -6 | -52 | -83 | -52 | 13 | 50 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.14x | 0.10x | 0.15x | 0.19x | 0.14x | 0.16x | 0.16x |
| Interest Coverage (x) | 13.68x | 20.30x | 11.85x | 10.32x | 6.03x | 3.31x | 3.66x |
| 1.98x | 1.84x | 1.80x | 1.69x | 1.98x | 1.89x | 2.11x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 2.36% | -10.19% | 2.42% | 22.02% | 27.29% | -9.35% |
| Operating Profit Growth % | 0.00% | 1.38% | -4.60% | 26.35% | 3.86% | -3.59% | -20.02% |
| Net Profit Growth % | 0.00% | 10.52% | -8.74% | 22.82% | -1.14% | -35.54% | -30.95% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -35.86% | -30.95% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 51.31x | 93.43x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2.43x | 2.97x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.26% | 0.21% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 19.48x | 31.09x |
Mar 2019
- EPS (₹)
- 10.28
- Book Value (₹)
- 73.69
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 12.17
- Operating Margin %
- 17.23%
- Net Margin %
- 9.81%
- ROE %
- 13.95%
- ROCE %
- 19.30%
- 8.80%
- Debtor Days
- 129
- Inventory Days
- 45
- Payable Days
- 161
- 13
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 13.68x
- 1.98x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 10.88
- Book Value (₹)
- 97.55
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 12.93
- Operating Margin %
- 17.06%
- Net Margin %
- 10.59%
- ROE %
- 12.94%
- ROCE %
- 16.54%
- 8.36%
- Debtor Days
- 136
- Inventory Days
- 47
- Payable Days
- 189
- -6
- Debt to Equity (x)
- 0.10x
- Interest Coverage (x)
- 20.30x
- 1.84x
- Revenue Growth %
- 2.36%
- Operating Profit Growth %
- 1.38%
- Net Profit Growth %
- 10.52%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 9.93
- Book Value (₹)
- 103.33
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 11.99
- Operating Margin %
- 18.12%
- Net Margin %
- 10.76%
- ROE %
- 9.89%
- ROCE %
- 12.99%
- 6.46%
- Debtor Days
- 166
- Inventory Days
- 36
- Payable Days
- 254
- -52
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 11.85x
- 1.80x
- Revenue Growth %
- -10.19%
- Operating Profit Growth %
- -4.60%
- Net Profit Growth %
- -8.74%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 12.19
- Book Value (₹)
- 113.56
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 16.92
- Operating Margin %
- 22.35%
- Net Margin %
- 12.90%
- ROE %
- 11.25%
- ROCE %
- 12.94%
- 7.11%
- Debtor Days
- 183
- Inventory Days
- 51
- Payable Days
- 317
- -83
- Debt to Equity (x)
- 0.19x
- Interest Coverage (x)
- 10.32x
- 1.69x
- Revenue Growth %
- 2.42%
- Operating Profit Growth %
- 26.35%
- Net Profit Growth %
- 22.82%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 11.64
- Book Value (₹)
- 145.25
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 16.67
- Operating Margin %
- 19.03%
- Net Margin %
- 10.46%
- ROE %
- 9.13%
- ROCE %
- 10.85%
- 5.87%
- Debtor Days
- 166
- Inventory Days
- 93
- Payable Days
- 311
- -52
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 6.03x
- 1.98x
- Revenue Growth %
- 22.02%
- Operating Profit Growth %
- 3.86%
- Net Profit Growth %
- -1.14%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 7.47
- Book Value (₹)
- 157.52
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 13.05
- Operating Margin %
- 13.11%
- Net Margin %
- 5.29%
- ROE %
- 4.94%
- ROCE %
- 8.46%
- 3.34%
- Debtor Days
- 123
- Inventory Days
- 106
- Payable Days
- 216
- 13
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 3.31x
- 1.89x
- Revenue Growth %
- 27.29%
- Operating Profit Growth %
- -3.59%
- Net Profit Growth %
- -35.54%
- -35.86%
- P/E (x)
- 51.31x
- P/B (x)
- 2.43x
- Dividend Yield %
- 0.26%
- 19.48x
Mar 2025
- EPS (₹)
- 5.16
- Book Value (₹)
- 162.23
- Dividend per Share (₹)
- 1.00
- Cash EPS (₹)
- 10.71
- Operating Margin %
- 8.87%
- Net Margin %
- 4.03%
- ROE %
- 3.23%
- ROCE %
- 5.77%
- 2.24%
- Debtor Days
- 139
- Inventory Days
- 136
- Payable Days
- 226
- 50
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 3.66x
- 2.11x
- Revenue Growth %
- -9.35%
- Operating Profit Growth %
- -20.02%
- Net Profit Growth %
- -30.95%
- -30.95%
- P/E (x)
- 93.43x
- P/B (x)
- 2.97x
- Dividend Yield %
- 0.21%
- 31.09x
Documents
Announcements
- Updates
2026-08-18 - Medicamen Biotech Limited has informed the Exchange regarding 'Intimation of Book Closure and Record Date in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) '.
- Copy of Newspaper Publication
2026-08-17 - Medicamen Biotech Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.